Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Notes to Rows 6, 8 and 9: See Item 2(a) below. Notes to Row 11: Based on 43,367,703 Ordinary Shares issued and outstanding of the Issuer as of November 27, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Notes to Rows 6, 8 and 9: See Item 2(a) below. Notes to Row 11: Based on 43,367,703 Ordinary Shares issued and outstanding of the Issuer as of November 27, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Notes to Rows 6, 8 and 9: See Item 2(a) below. Notes to Row 11: Based on 43,367,703 Ordinary Shares issued and outstanding of the Issuer as of November 27, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Notes to Rows 6, 8 and 9: See Item 2(a) below. Notes to Row 11: Based on 43,367,703 Ordinary Shares issued and outstanding of the Issuer as of November 27, 2024.


SCHEDULE 13G



 
BVCF IV, L.P.
 
Signature:By: BVCF IV GP, Ltd., its general partner /s/ Zhi Yang
Name/Title:Zhi Yang/Director
Date:02/11/2025
 
BEYEOTECH
 
Signature:/s/ Bernard Yang Feng
Name/Title:Bernard Yang Feng/Director
Date:02/11/2025
 
BVCF IV GP, Ltd.
 
Signature:/s/ Zhi Yang
Name/Title:Zhi Yang/Director
Date:02/11/2025
 
Zhi Yang
 
Signature:/s/ Zhi Yang
Name/Title:Zhi Yang
Date:02/11/2025
Exhibit Information

Joint Filing Agreement dated April 28, 2023 https://www.sec.gov/Archives/edgar/data/1761158/000119312523131200/d499516dex991.htm